InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
3
T+90 hit rate
33%
T+90 mean return
-5.8%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Baumal Caroline, Chief Medical Officer. Insider active across 2 companies, notably Apellis Pharmaceuticals, Inc.. Aggregated, 8 filings have been published. Split: 0 buy · 3 sells. Total volume traded: €297k. History available since 3 January 2023. The latest transaction was disclosed on 21 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
86,525 sharesCommon StockSEC:0001193125-26-224577:0
86,525 sharesCommon StockSEC:0001193125-26-224577
1,853 shares@ US$29.958218.1% of flowCommon StockSEC:0001127602-25-001612:0
39,594 shares0Common StockSEC:0001127602-25-001612:1
2,816 shares@ US$33.81231.1% of flowCommon StockSEC:0001127602-25-001011:0
25,445 shares0Common StockSEC:0001127602-24-001432:0
2,751 shares@ US$60.053450.8% of flowCommon StockSEC:0001127602-24-000962:0
35,549 shares0Common StockSEC:0001127602-23-001003:0
8 of 8 declarations
About Baumal Caroline
Caroline Baumal is the Chief Medical Officer at Apellis Pharmaceuticals, Inc. In this role, she is responsible for the medical and clinical aspects of the company's products. Her medical expertise is essential to ensure the safety and efficacy of the treatments developed by Apellis.
